Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Brazil
2,016
Leprosy
Autoimmune
1.22
11.06
9.54
61+
Female
78,563
77.08
2.28
4.37
Medication
20,016
No
86.81
2,023
0.05
15,506
0.41
36.11
Russia
2,021
Diabetes
Autoimmune
14.29
1.57
7.12
0-18
Female
920,061
70.1
2.61
4.03
Vaccination
38,676
No
87.97
2,370
0.24
87,314
0.75
39.47
Turkey
2,020
Parkinson's Disease
Bacterial
19.87
2.85
8.83
0-18
Other
869,772
95.5
4.54
6.46
Therapy
42,978
No
91.8
66
3.67
14,709
0.53
48.44
Mexico
2,008
Dengue
Parasitic
3.21
9.93
3.15
19-35
Other
173,719
78.85
0.58
4.91
Therapy
49,028
No
92.23
3,335
4.82
13,343
0.53
74.5
Australia
2,020
Malaria
Genetic
12.89
12.34
1.52
36-60
Other
108,176
54.73
3.32
5.35
Medication
9,153
Yes
85.7
3,411
1.03
13,201
0.62
34.93
Australia
2,006
Hypertension
Respiratory
13.42
7.87
6.43
19-35
Female
635,718
86.96
1.89
3.9
Medication
34,292
No
59.44
23
5.58
54,642
0.61
24.4
Nigeria
2,013
COVID-19
Genetic
16.42
3.73
9.38
0-18
Other
54,680
79.4
1.94
1.49
Therapy
18,609
Yes
59.41
3,752
8.61
1,528
0.46
70.12
Japan
2,013
Alzheimer's Disease
Metabolic
6.24
2.74
0.38
19-35
Female
574,312
88.68
0.82
4.68
Vaccination
22,952
Yes
51.68
2,959
0.87
17,778
0.8
34.27
South Korea
2,023
Ebola
Chronic
9.74
11.62
3.87
0-18
Male
15,852
91.8
2.92
8.71
Vaccination
33,473
Yes
76.67
3,585
3.33
33,284
0.53
47.29
Saudi Arabia
2,024
Malaria
Chronic
13.4
11.44
9.59
61+
Other
259,325
63.99
3.16
5.84
Surgery
14,273
Yes
90.56
4,937
7.2
78,046
0.64
70.02
China
2,023
Cancer
Genetic
18.82
1.97
0.55
19-35
Male
421,832
87.89
1.42
3.33
Vaccination
49,084
Yes
83.95
2,231
1.4
49,305
0.65
30.79
China
2,013
Hepatitis
Metabolic
15.83
0.95
2.06
36-60
Male
696,874
72.54
2.28
8.5
Surgery
44,472
Yes
54.76
1,410
9.36
33,958
0.83
40.23
Australia
2,003
Measles
Cardiovascular
13.62
5.88
2.9
61+
Male
664,678
90.61
3.14
4.88
Vaccination
16,650
No
58.4
3,739
9.92
64,000
0.56
84.69
Japan
2,010
Tuberculosis
Metabolic
8.19
14.32
5.89
0-18
Other
313,216
57.24
2.33
7.01
Surgery
13,382
No
90.54
3,489
2.94
44,123
0.41
52.46
Turkey
2,007
Dengue
Bacterial
15.55
12.9
6
61+
Male
445,868
73.53
0.85
7.33
Therapy
46,459
No
83.86
836
1.69
94,847
0.5
37.61
South Korea
2,007
Cholera
Genetic
5.13
6.29
2.12
61+
Other
641,206
85.48
0.67
4.46
Surgery
4,233
Yes
65.96
1,354
3.11
27,899
0.74
47.13
Mexico
2,009
Ebola
Autoimmune
12.49
5.49
6.46
36-60
Male
970,906
92.74
3.13
2.29
Medication
10,256
Yes
94.83
556
7.33
92,918
0.56
34.93
USA
2,023
Dengue
Parasitic
12
5.12
9.81
19-35
Male
825,564
60.93
2.6
7.1
Surgery
45,724
Yes
52.79
2,735
9.81
22,960
0.84
59.6
USA
2,004
Leprosy
Parasitic
12.46
8.02
2.27
36-60
Male
741,313
51.61
3.24
5.53
Surgery
26,577
No
93.78
4,853
1.79
69,394
0.51
52.76
Russia
2,017
Diabetes
Respiratory
15.96
10.06
5.16
19-35
Male
753,582
61.65
2.47
5.49
Medication
48,049
No
58.86
4,099
1.28
48,858
0.59
75.36
Saudi Arabia
2,007
Diabetes
Parasitic
5.5
14.36
9.2
19-35
Other
546,335
71.61
3.51
8.95
Surgery
37,978
No
54.99
3,313
4.68
65,831
0.71
38.02
Italy
2,007
Hepatitis
Bacterial
10.86
4.27
7.6
36-60
Female
786,494
87.48
0.53
1.4
Surgery
32,906
Yes
67.71
3,487
9.22
80,649
0.46
57.03
Russia
2,000
Polio
Cardiovascular
18.78
13.15
8.79
0-18
Female
502,933
68.39
0.81
7.72
Therapy
31,272
Yes
64.8
1,625
0.13
99,433
0.62
64.48
India
2,002
Parkinson's Disease
Bacterial
8.39
13.32
7.64
19-35
Other
664,263
82.12
2.78
8.63
Vaccination
31,921
Yes
96.66
298
9.55
51,795
0.54
67.42
UK
2,014
Zika
Parasitic
7.72
0.19
1.47
0-18
Other
859,912
74.33
1.35
1.9
Medication
19,614
Yes
66.85
4,547
0
37,449
0.79
79.34
Germany
2,015
Leprosy
Parasitic
7.71
9.52
5.16
36-60
Female
242,729
79.06
4.17
9.9
Medication
43,093
No
93.67
2,410
3.78
58,533
0.42
68.89
India
2,000
Tuberculosis
Neurological
4.11
12.63
3.34
19-35
Other
487,858
72.5
3.81
1.75
Therapy
36,473
Yes
63.61
1,006
4.71
96,423
0.49
82.85
Argentina
2,018
Influenza
Cardiovascular
10.17
3.67
1.15
19-35
Female
547,008
76.27
3.33
8.61
Surgery
28,770
No
89.84
2,174
7.55
45,271
0.54
34
Italy
2,017
Polio
Neurological
5.82
12.64
4.69
0-18
Female
780,304
96.24
2.36
9.83
Therapy
44,177
No
72.86
2,317
8.27
52,017
0.43
30.09
Germany
2,018
Alzheimer's Disease
Cardiovascular
16.48
0.49
7.75
0-18
Male
604,361
64.79
0.68
4.45
Vaccination
11,595
No
96.23
4,504
3.45
16,510
0.82
54.13
Argentina
2,017
Malaria
Cardiovascular
13.13
9.85
1.08
36-60
Female
445,865
70.18
2.04
5.28
Therapy
20,492
No
53.74
3,786
9.42
50,516
0.5
67.37
Germany
2,020
Polio
Viral
1.6
10.78
2.3
36-60
Other
583,108
68.29
4.65
3.78
Therapy
31,708
No
97.8
3,740
7.11
85,897
0.62
55.51
Canada
2,010
Malaria
Neurological
4.26
13.73
0.16
36-60
Male
996,493
64.39
4.74
1.9
Medication
37,562
Yes
67.9
4,134
2.93
70,904
0.77
70.87
Indonesia
2,016
Ebola
Respiratory
5.09
9.7
0.37
19-35
Female
794,791
79.41
2.98
8.97
Medication
7,037
No
91.09
408
4.93
7,672
0.88
41.64
Brazil
2,000
Zika
Metabolic
14.48
5.42
3.49
61+
Female
391,316
98.41
1.34
7.7
Therapy
1,036
Yes
71.26
4,789
5.72
54,529
0.66
22.22
Indonesia
2,011
Measles
Genetic
0.7
7.19
5.33
36-60
Other
622,322
73.18
3.13
7.37
Vaccination
15,470
Yes
52.66
26
8.16
54,588
0.49
41.92
France
2,008
Rabies
Autoimmune
4.21
8.48
3.49
19-35
Other
960,461
55.28
1.5
4.19
Therapy
8,740
No
72.57
1,719
3.93
42,149
0.75
74.76
Nigeria
2,017
Diabetes
Parasitic
12.36
13.74
2.65
61+
Male
66,129
93.82
4.61
1.86
Surgery
25,753
Yes
94.81
1,792
5.5
67,111
0.8
52.95
Saudi Arabia
2,020
Rabies
Viral
13.62
3.99
6.26
61+
Male
492,240
82.48
2.13
1.03
Medication
18,272
No
78.6
2,439
3.29
72,145
0.74
24.82
Australia
2,019
Influenza
Cardiovascular
6.98
3.24
5.95
36-60
Other
530,109
80.27
4.06
7.35
Surgery
37,990
No
86.87
2,150
0.29
53,867
0.69
80.69
South Korea
2,024
Parkinson's Disease
Metabolic
19.7
12.87
6.32
36-60
Male
554,052
91.59
2.68
9.11
Therapy
48,474
No
97.27
4,279
7.01
12,187
0.69
23.56
Japan
2,019
Dengue
Metabolic
19.2
1.97
7.48
61+
Female
376,897
73.74
0.7
5.93
Medication
34,135
No
64.37
3,811
3.14
26,749
0.45
67.9
UK
2,011
Diabetes
Genetic
5.72
10.06
1.41
19-35
Female
161,946
67.48
4.25
6.16
Therapy
9,037
No
80.78
1,377
6.2
91,002
0.41
72.18
South Korea
2,023
Rabies
Chronic
12.65
1.03
4.51
0-18
Male
485,252
91.37
4.34
8.99
Therapy
45,917
Yes
76.25
3,751
9.47
78,729
0.7
76.45
Australia
2,024
Parkinson's Disease
Autoimmune
9.28
6.83
2.54
0-18
Female
212,421
72.33
0.62
1.88
Therapy
44,685
No
67.4
668
8.6
61,135
0.55
83.2
Saudi Arabia
2,002
Diabetes
Cardiovascular
10.88
1.36
7.36
61+
Female
747,469
83.96
4.02
6.89
Medication
38,584
Yes
97.16
1,287
6.48
33,433
0.83
51.69
USA
2,005
Polio
Parasitic
7.12
13.74
5.82
19-35
Female
331,204
89.47
4.44
8.34
Therapy
33,487
Yes
74.97
3,499
4.26
1,260
0.87
61.63
Australia
2,016
Hypertension
Autoimmune
8.63
1.82
8.79
61+
Male
119,821
68.25
0.53
4.75
Medication
13,684
No
82.17
3,334
5.04
54,058
0.48
49.33
Australia
2,020
HIV/AIDS
Parasitic
6.06
4.94
8.39
61+
Other
634,580
52.03
3.17
1.9
Vaccination
2,135
Yes
76.59
1,098
4.86
73,531
0.86
64.03
Saudi Arabia
2,001
Influenza
Neurological
6.23
14.48
7.53
19-35
Male
122,738
57.7
4.78
6.79
Medication
47,709
Yes
98.83
2,900
5.94
70,479
0.82
40.69
Australia
2,015
Ebola
Genetic
1.38
8
5.82
19-35
Other
549,267
65.6
1.35
2.91
Surgery
14,131
Yes
88.82
374
0.87
76,932
0.49
79.87
Japan
2,004
Rabies
Autoimmune
0.35
9.2
4.61
61+
Female
108,017
67.46
0.8
5.69
Surgery
48,684
No
81.76
2,133
9.15
99,547
0.55
62.18
Brazil
2,012
COVID-19
Bacterial
16.96
10.94
1.14
0-18
Female
649,479
55.18
4.19
7.33
Surgery
4,420
No
69.43
3,022
9.01
39,858
0.63
52.51
South Africa
2,000
Ebola
Bacterial
10.43
12.28
4.08
61+
Male
628,263
61.13
2.79
7.22
Therapy
21,268
No
77.85
1,716
6.49
67,632
0.69
63.85
Italy
2,020
Rabies
Chronic
9.92
2.92
2.57
61+
Female
833,716
75.16
2.12
0.93
Therapy
23,376
No
77.88
4,432
3.25
92,888
0.7
49.97
USA
2,012
Alzheimer's Disease
Chronic
12.6
11.93
4.71
0-18
Male
792,327
72.73
3.45
5.25
Surgery
1,643
No
65.47
3,823
1.59
91,464
0.44
28.6
China
2,001
Dengue
Parasitic
8.68
1.07
2.32
36-60
Other
112,276
77.59
3.42
0.81
Therapy
1,976
Yes
61.64
4,734
9.41
99,269
0.9
66.95
Argentina
2,014
Asthma
Neurological
12.73
8.53
3.42
0-18
Female
267,470
55.57
1.27
3.96
Medication
39,981
Yes
50.41
4,447
4.42
78,847
0.79
54.25
China
2,019
Alzheimer's Disease
Bacterial
12.37
1.92
8.57
61+
Male
674,211
86.77
1.15
3.22
Vaccination
30,285
No
58.38
521
0.4
12,288
0.84
78.13
Turkey
2,007
Dengue
Autoimmune
8.83
9.3
3.08
61+
Male
327,893
51.36
3.12
4.87
Medication
38,755
No
58.18
4,823
2.06
61,524
0.9
52.11
UK
2,016
COVID-19
Genetic
17.8
9.5
8.53
61+
Other
988,281
88.05
2.9
6.97
Vaccination
33,812
Yes
55.19
2,484
6.08
94,279
0.44
23.67
Nigeria
2,021
Asthma
Bacterial
13.26
5.25
9.15
36-60
Other
252,392
63.71
2.41
3.2
Therapy
949
Yes
88.03
2,076
1.84
71,761
0.58
72.54
Australia
2,003
Leprosy
Respiratory
12.86
9.48
2.11
36-60
Other
941,410
72.74
1.99
1.96
Medication
13,611
Yes
85.86
2,390
4.79
73,626
0.55
46.91
Turkey
2,011
Zika
Bacterial
9.26
12.59
8.1
61+
Male
863,096
94.83
1.39
6.03
Medication
49,528
Yes
76.29
831
8.35
42,938
0.47
24.87
Australia
2,019
Zika
Chronic
7.27
1.81
8.44
36-60
Female
923,238
51.58
4.97
2.57
Surgery
21,613
Yes
87.9
3,464
6.53
36,762
0.62
82.5
Mexico
2,002
Cholera
Neurological
15.48
2.37
1.28
19-35
Male
795,152
84.52
1.66
4.09
Therapy
5,227
Yes
78.25
3,299
2.32
62,623
0.51
76.02
Russia
2,005
HIV/AIDS
Bacterial
13.66
10.43
0.54
36-60
Male
150,727
56.03
1.18
0.99
Surgery
10,313
No
98.5
970
1.49
31,288
0.78
47.86
Turkey
2,011
Measles
Genetic
1.9
6.1
3.18
36-60
Male
380,677
82.38
1.07
6.2
Medication
25,818
No
88.93
34
7.12
80,121
0.89
46.02
Australia
2,011
Hypertension
Respiratory
3.45
4.54
4.9
61+
Male
593,948
74.16
2.23
6.26
Vaccination
40,570
Yes
87.63
1,313
2.9
11,114
0.44
60.02
Mexico
2,024
Rabies
Autoimmune
8.75
11.65
2.55
36-60
Male
62,382
51.41
0.89
5.62
Therapy
11,265
Yes
96.72
4,162
6.38
34,684
0.73
64.67
South Korea
2,018
COVID-19
Autoimmune
5.68
5.18
7.41
61+
Male
130,852
79.45
1.32
5.3
Surgery
42,881
Yes
69.89
286
9.92
68,898
0.83
39.47
Turkey
2,007
Cancer
Autoimmune
11.36
6.84
0.33
19-35
Other
422,894
56.41
3.01
1.39
Surgery
478
Yes
72.14
781
9.31
59,914
0.8
88.13
Germany
2,009
HIV/AIDS
Respiratory
0.97
3.97
2.22
0-18
Female
881,564
89.55
4.04
6.1
Surgery
46,305
No
61.33
3,311
5.89
23,002
0.77
37.53
UK
2,022
Ebola
Infectious
13.47
1.67
7.39
0-18
Male
757,339
62.94
1.86
2.72
Surgery
22,504
Yes
93.31
1,707
3.28
29,661
0.44
65.25
UK
2,020
Diabetes
Bacterial
0.64
7.28
1.91
19-35
Male
140,343
53.97
1.9
9.73
Vaccination
33,721
No
95.04
2,041
6.01
58,838
0.5
36.66
China
2,024
Rabies
Chronic
6.38
12
4.29
61+
Other
505,477
92.74
1.37
9.02
Vaccination
31,813
Yes
57.61
1,872
8.87
41,320
0.69
53.19
India
2,023
Ebola
Parasitic
5.41
5.39
8.18
36-60
Other
202,968
81.03
1.61
8.6
Medication
48,771
Yes
96.97
1,854
5.13
11,353
0.67
27.29
Saudi Arabia
2,014
Asthma
Respiratory
12.52
8
3.27
19-35
Male
679,341
53.21
2.86
9.82
Surgery
21,986
Yes
59.25
4,051
9.09
42,231
0.9
55.44
Indonesia
2,017
Zika
Infectious
11.76
3.46
4.69
36-60
Female
927,687
55.55
1.49
9.91
Surgery
25,038
No
57.22
3,544
3.75
53,300
0.63
59.25
Japan
2,024
Hypertension
Cardiovascular
15.89
1.56
3.22
61+
Male
505,520
99.7
2.43
5.91
Surgery
22,596
No
66.54
2,959
5.08
19,393
0.42
67.6
France
2,015
Tuberculosis
Chronic
16.5
5.67
3.37
36-60
Male
758,816
69.48
1.08
8.17
Surgery
22,490
No
95.16
1,044
3.36
87,642
0.81
43.04
Australia
2,022
Parkinson's Disease
Respiratory
1.21
11.67
7.07
36-60
Female
968,955
84.01
1.64
8.61
Therapy
34,503
Yes
64.35
996
6.53
45,564
0.75
62.99
Nigeria
2,019
Polio
Chronic
8.75
3.59
8.32
19-35
Other
190,562
72.22
1.89
7.42
Vaccination
7,261
No
85.8
3,348
3.45
97,990
0.48
25.25
Turkey
2,011
Hepatitis
Genetic
19.67
8.35
0.46
19-35
Male
269,256
73.95
3.36
8.22
Surgery
40,169
No
58.02
62
8.43
88,099
0.43
78.01
France
2,003
Influenza
Chronic
12.3
5.28
8.24
19-35
Other
957,488
75.8
3.03
8.13
Surgery
8,650
No
91.51
3,832
7.11
98,804
0.66
58.65
Indonesia
2,020
Ebola
Neurological
1.37
0.11
0.71
36-60
Female
107,468
77.8
3.76
3.67
Surgery
44,598
No
66.37
3,606
6.14
30,664
0.63
55.09
Turkey
2,004
Tuberculosis
Autoimmune
12.75
10.41
1.88
61+
Female
322,573
94.26
2.41
6.39
Therapy
20,475
No
81.02
4,142
2.6
54,219
0.59
43.73
India
2,022
Cancer
Neurological
12.16
5.23
4.93
61+
Female
462,287
83.75
0.74
6.91
Medication
32,568
Yes
92.27
859
0.27
78,009
0.75
31.35
France
2,011
Alzheimer's Disease
Infectious
1.38
1.53
9.42
19-35
Male
181,315
71.72
2.7
8.55
Surgery
10,746
No
74.96
145
8.71
95,953
0.52
36.68
China
2,013
Parkinson's Disease
Genetic
18.11
9.69
7.56
61+
Other
245,909
60.16
1.86
2.53
Vaccination
15,331
No
64.27
4,961
1.31
53,838
0.89
55.44
Indonesia
2,000
Influenza
Neurological
5.34
4.94
5.99
36-60
Female
681,502
77.7
3.78
2.08
Surgery
28,124
Yes
94.56
4,420
7.73
18,554
0.81
21.94
Canada
2,022
Zika
Parasitic
9.44
11.41
0.52
36-60
Other
745,297
63.19
1.97
0.64
Medication
7,225
No
88.15
1,192
7.08
43,161
0.71
35.54
Russia
2,004
Asthma
Metabolic
6.73
0.94
1.31
0-18
Female
239,170
83.78
0.87
3.5
Surgery
18,996
No
55.62
3,480
6.52
13,449
0.56
49.91
Argentina
2,011
Leprosy
Infectious
12.29
14.99
1.94
61+
Male
23,450
67.16
3.15
2.16
Therapy
23,639
Yes
72.18
1,342
2.19
7,801
0.71
74.7
Russia
2,005
Zika
Respiratory
18.94
0.55
8.57
0-18
Other
94,432
82.88
1.87
7.01
Vaccination
28,086
Yes
54.8
448
7.26
34,306
0.61
83.05
Nigeria
2,018
Malaria
Neurological
16.68
7.65
3.93
19-35
Male
761,670
64.94
2.82
7.2
Surgery
40,877
No
89.53
44
9.87
78,847
0.55
83.3
Argentina
2,004
Parkinson's Disease
Chronic
1.85
11.9
1.07
0-18
Other
429,160
81.16
2.17
0.87
Medication
45,822
No
79.78
1,994
0.9
39,147
0.47
25.19
Russia
2,011
Dengue
Genetic
13.59
4.93
5.69
36-60
Male
588,749
72.36
3.94
9.41
Vaccination
25,076
No
55.83
1,453
7.43
55,758
0.64
74.09
Canada
2,017
Zika
Metabolic
17.12
11.21
9.83
0-18
Other
994,638
69.64
1.59
8.99
Surgery
32,605
No
80.55
1,423
3.32
59,121
0.66
73.08
Canada
2,019
Parkinson's Disease
Metabolic
7.67
11.75
9.43
19-35
Female
74,107
63.52
4.78
5.83
Surgery
45,020
No
81.39
1,309
9.86
15,781
0.9
40.58